MORGAN STANLEY PLC/PUT/ZOETIS/175/0.1/21.03.25 | Market Closed - Börse Stuttgart 19:42:32 14/06/2024 BST | ||
| 1.76 EUR | +7.98% |
|
| Current month | -2.22% | ||
| 1 month | -6.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ZOETIS INC.
Latest news about ZOETIS INC.
More news
| Date | Price | Change |
|---|---|---|
| 14/06/24 | 1.76 | +7.98% |
| 13/06/24 | 1.63 | +10.88% |
| 12/06/24 | 1.47 | +6.52% |
| 11/06/24 | 1.38 | +0.73% |
| 10/06/24 | 1.37 | -7.43% |
Delayed Quote Börse Stuttgart
Last update June 14, 2024 at 07:42 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | ZOETIS INC. |
| Issuer | Morgan Stanley |
| WKN | MB5BJK |
| ISIN | DE000MB5BJK9 |
| Date issued | 05/04/2023 |
| Strike | 175 $ |
| Maturity | 21/03/2025 (279 Days) |
| Parity | 10 : 1 |
| Emission price | 2.6 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.48 € |
|---|---|
| Lowest since issue | 0.94 € |
| Spread | 0.03 € |
| Spread % | 1.71% |
Company Profile
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows:
- pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%);
- livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%);
- other (1.1%).
Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%).
At the end of 2022, the group has 29 production sites worldwide.
The United States accounts for 53.4% of net sales.
Sector
-
Consensus: Zoetis Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
170.6
USD
Average target price
210.2
USD
Spread / Average Target
+23.22%
- Stock Market
- Warrants
- Warrant